LIVE WEBCASTS


The Basics of the Sunshine Act and the Implications for Your Business
Thursday, February 23, 2012 - 12:00 PM EST

Over the last two years, most manufacturers have implemented reporting systems that will pull data from their existing source systems to create their Transparency Reports. Many companies have not created full end-to-end solutions to resolve the new Healthcare Reform laws. Many still use a manual approach to conquer the challenges of identifying, collecting, aggregating, and reporting transparency data. Others have chosen to invest in systems and revamp business processes by implementing reporting solutions to aggregate and report. Throughout 2011, many manufacturers gave priority to implementing Spend Reporting Applications (Engines), in order to meet the January 1, 2012 data collection milestone, without addressing issues identified in the "up-stream" processes across the Transparency Reporting Continuum. Since CMS has delayed the requirements to collect the spend information (required in section 1128G) manufacturers have been given the opportunity to either ?catch up? in their implementation efforts and/or address up-stream issues that may result in compliance gaps.

Register Free at http://pharmexec.com/sunshine

Sponsor:
revitas


Cloud-Based Customer Management: When Efficiency Reigns, Opportunities Pour
Tuesday, February 28, 2012 - 1:00 PM EST

There are dozens of reasons life sciences organizations need the right HCP and HCO data compliance, untapped markets, maximizing HCO contract values, and physician outreach to name a few. To meet this bottom-line driven need, [a generation of] IT companies was born to help life sciences master their data. But a master data management (MDM) strategy and technology solution is only one part of the equation. Essential people and processes must ensure steady data acquisition and ongoing management. That part of the equation often falls on internal resource-constrained teams. And let's face it, keeping up with the highly dynamic healthcare workforce and the institutions where they work is beyond daunting. It's time to maximize past investments and see why cloud-based data management can rapidly fix your data accuracy challenge and perhaps, more importantly give your organization:
- a holistic view of your customer
- an effective way to act on ever-changing information,
- the ability to seamlessly absorb that information across business areas,
- easier adaptability to rigorous federal, state and local regulations.

Register Free at http://pharmexec.com/cloud

Sponsor:
Health Science Market


Meeting Global Patient Demand for Access to Medicines Prior to Approval and Launch
Wednesday, February 29, 2012 - 1:00 PM EST

Patients are more educated and empowered with regard to their health than ever before.  Coupled with greater transparency of drug pipelines, patients with unmet medical needs, their advocates and physicians are increasingly and aggressively seeking access to drugs via alternative routes rather than waiting for the traditional process of approval to run its course.
To meet this demand, companies can use Managed Access Programs to provide global, pre-approval access to their innovative medicines, in full compliance with regulatory authorities.
 
Managed Access Programs encompass a variety of regulatory approaches that enable access to medicines that are not available to patients for a number of reasons including those drugs that:
 
•      Are still in clinical development
•      May never be approved, but still have medicinal value for a small population (for example, some orphan drugs)
•      Are approved in one country, but not another
•      Have been discontinued in a particular market

This webinar will present an overview of Managed Access Programs, how they can be leveraged to meet global patient demand, and the benefits afforded all stakeholders. The session will also offer the patient advocacy perspective on the need for innovative routes to access and discuss how patients typically become aware of and navigate different access options, a particular challenge if treatments are not commercially available. The discussion will highlight strategies for establishing partnerships with patient groups to help facilitate a successful Managed Access Program.

Register Free at http://pharmexec.com/demand

Sponsor:
Idis


Utilization of Rasch Measurement Models for Assessing Validity: A Mixed Methods Approach
Wednesday, March 14, 2012 - 10:30 AM EDT

Development of reliable and valid patient or clinician reported outcome measures (PROs and ClinROs, respectively) requires a deep understanding of the patient population but also of the underlying latent traits of symptomology and disease impact or quality of life. Modern psychometric theory as opposed to complete reliance on classical test theory approaches including Rasch measurement models have been increasingly used in the development and refinement of PRO measures and have publicly been endorsed by the FDA. Rasch analysis can be implemented iteratively during instrument development as well as psychometric evaluation to fully understand the content and construct validity of PRO measures prior to use in Phase III trials

Register Free at http://pharmexec.com/rasch

Sponsor:
Adelphi Values

ON-DEMAND WEBCASTS NOW AVAILABLE FOR REPLAY

Thought Leader Identification, Prioritization, & Engagement Through Social Network Analytics
Recorded on: December 1, 2011

Join us as we examine social network analytics (SNA) and share effective strategies to identify, prioritize and engage thought leaders at biopharma and medical device companies. Three expert panelists will share their unique views about:
- Implementation of thought leader programs.
- Strategic organizational alignment and change management.
- Social network analytics technology solutions.

Register Free at http://pharmexec.com/social

Sponsor:
SAS

Analyze This: Viewing Pharma Markets from Wall Street?s Perspective
Recorded on: October 6, 2011

Pharmaceutical leaders have all experienced the power of financial analyst notes. Whether negative or positive for your brand, they wield a great deal of influence on the stock price of your company, and as such are important to understand. We?ll discuss business strategies from the point of view of professional investors. Through a review of 12 months of market data, we will look at industry trends through the lens of Wall Street, and show you the elements that pique interest and commentary.

Register Free at http://pharmexec.com/wallstreet

Sponsor:
Wolters Kluwer

Effective Resource Planning: Reducing Clinical Project Risk and Operating Cost
Recorded on: September 15, 2011

Accurate resource planning remains one of the biggest challenges facing biopharmaceutical and medical device companies today, with poor planning leading to increased project risk and higher development costs. This webcast will demonstrate how leading life sciences companies are leveraging effective resource planning to allocate resources efficiently for individual studies as well as across the project portfolio -- reducing project risk, lowering operating costs, and improving employee morale and productivity.

Attend " Effective Resource Planning" to discover:
- How sponsors are making fact-based, strategic decisions to extract the most out of their resources in a constantly shifting operating environment.
- What methods deliver accurate resource forecasts at either the project or portfolio level, based on when the work will actually occur.
- How program planning, tracking project status, and reforecasting work together to enable effective resource planning.

Register Free at http://pharmexec.com/planning

Sponsor:
ClearTrial

Optimizing the Multi-Sponsor REMS Experience (Risk Evaluation & Mitigation Strategies)
Recorded on: September 18, 2011

Managing large, complex REMS programs across multiple manufacturers is a difficult task. The organizations involved in these interactions must deal with competing agendas, entangled legal relationships, and multiple business approaches.

The essential pillars of a successful program include: efficient/transparent communication identification of a formalized decision-making process and governance, cost sharing and effective on-boarding/exiting of sponsors.

This webcast will discuss in detail the lessons learned from facilitating the management of current multi-sponsor REMS programs and experiences that can be leveraged for use in future multi-sponsor REMS. This event will provide insights into the design, implementation and operation of large, complicated programs.

Register Free at http://pharmexec.com/multisponsor

Sponsor:
PricewaterhouseCoopers LLP

The New Digital Standard for Interacting With Life Sciences Customers
Recorded on July 20, 2011

This webcast will highlight how the digital channel is fundamentally changing the way customers make health related decisions, and how life sciences product manufacturers are retooling their approaches to effectively create value when engaging with customers.

This New Digital Standard for Interacting With Customers calls for new marketing rules, new strategies and new operating models to execute with speed, consistency and effectiveness. As customers consume more digital media and interact with one another via digital outlets, manufacturers need to redefine their value proposition in a world of anytime, anywhere access to information within the confines of our regulated speech industry.

Join a panel of experts who will discuss the significant changes to marketing activities and resource models due to the rise of the digital channel. During the webcast, the panelists will share six key areas for marketing teams to address the changing expectations of customers in the digital age. By addressing each of these areas, life sciences companies can drive revenue growth, brand differentiation and economic value through the digital channel.

Register Free at http://pharmexec.com/digitalstandard

Sponsor:
PricewaterhouseCoopers LLP

Customer Intimacy - The Pharma Challenge
Thursday, May 19, 2011 at 2:00 PM EDT

One of the key challenges and areas of focus for the pharmaceutical industry is increasing customer intimacy, be that understanding the perceptions, behaviors, and needs of consumers and patients to support increased adherence or embracing the challenges within the healthcare professionals daily routine to identify opportunities to delivery information and services which provide true "value".

In order to deliver upon either of these objectives, the challenge facing pharma is gaining deep customer insights and intimacy to identify and deliver relevant information and messaging, thereby driving customer engagement, and in turn creating deeper relationships. This process of gaining deeper customer insights starts with analyzing the data available about each customer in new ways.


Register Free at http://pharmexec.com/pharmachallenge

Sponsor:
SAS

Leveraging the Power of Predictive, Visual Analytics To Maximize Research, Development and Commercial Operations
Thursday, June 9, 2011 at 11:00 AM EDT

Simplyfying human-data interaction is one of the keys to better decision making across research, development and commercial operations processes. We will explore the capabilities of a sophisticated data visualization and analytics platform that provides reliable navigation through the vast amounts of data generated to run a life science organization providing a clear path to actionable decisions, reliably, rapidly and reproducibly. Learn how the world's leading pharmaceutical, biotech, medical device, and contract research organizations leverage predictive and visual analytics to discover new therapeutics, develop their pipeline of assets, launch their drugs to the market, and align marketing and sales campaigns to maximize return on their enterprise information investments.

Register Free at http://pharmexec.com/leveraging

Sponsor:
TIBCO Spotfire Life Sciences

Supply Chain Strategy: Managing risk and opportunity in a changing global landscape
Recorded on: April 26, 2011

The supply chain represents a significant amount of the cost base of most bio-pharmaceutical companies and is the critical link between the laboratory and the marketplace. Over the years, improvements made in supply chain operations have focused largely on ways to reduce cost and gain efficiencies in scale. Yet, powerful regulatory and market forces have created new incentives for pharmaceutical companies to fundamentally rethink the way they will manufacture and distribute products in the future, and to re-imagine the role of the supply chain in driving strategic growth, brand differentiation and economic value in the health continuum.

In this Webcast, a panel of experts will discuss significant changes the pharmaceutical supply chain is expected to undergo in the coming years and then explore potential scenarios for how pharmaceutical companies might restructure their supply chain strategy and operating models, depending on their unique product portfolio and channel strategy. The discussion will focus on the risks, opportunities and challenges in each of the four future supply chain models -- virtual manufacturer, service innovator, a mass market manufacturer or a profit center - identified by PricewaterhouseCoopers in its groundbreaking report Pharma 2020: Supplying the Future: Which path will you take?

Register Free at http://pharmexec.com/supplychain

Sponsor:
PricewaterhouseCoopers LLP


Critical Path Decisions for the 4 C's in Life Sciences: Buy, Subscribe or Outsource Your "Order to Cash", Contracts, Chargebacks and Compliance Systems
Recorded on: April 14, 2011

In today's highly competitive and complex life sciences industry, effective contract management and regulatory compliance are critical to your success. Pharmaceutical and biotech companies are continually looking for ways to retain more revenue from commercial contracts, minimize overpayments of chargebacks and incentive rebates while maintaining compliance in a high-stakes regulatory environment that imposes stiff penalties for infractions.

Jeff White, Director of Financial and Customer Services for Owen Minor HealthCare Logistics, and Jack Payne, Vice President of CDC Software, reveal the industry specific technologies that can streamline your 4 "C" business processes, "Order to Cash", Contracts, Chargebacks and Compliance with expanded functionality, improved usability, and greater automation.

To conserve cash and maximize profits, there are several investment options available, in terms of implementing the 4 "C" business processes. Which investment best fits your business model: the purchase of an on-premise application, a monthly subscription to a "in the cloud" application, or the outsourcing of these processes to a life sciences BPO provider? Our experts present a self evaluation checklist to help you make this critical investment decision.

Register Free at http://pharmexec.com/4c

Sponsor:
CDC Software

Unfolding the Road Map of Marketplace Influencers- New Approaches to Optimize Local Level Marketing to Payers, Practitioners and Patients
Recorded on: April 12, 2011

Pharmaceutical companies are evolving their marketing strategies to customize messages and tactics around key influencers. Localizing marketing efforts to respond more proactively to marketplace events can provide tremendous competitive advantage. Performing a thorough customer analysis that examines these "influencers" can help you identify differences in treatment patterns, understand how product prescribing and medication purchasing patterns may vary, and provide critical direction in your brand planning with key customer segments. This analysis identifies WHO makes or influences treatment decisions, from regulators and payers to pharmacists, physicians, and patients. By identifying the influencer, assessing the size and extent of influence, and determining the degree to which their behavior and attitudes can or should be modified, you can determine how best to take advantage of market opportunities and manage issues that should be addressed, including potential hurdles the product must overcome to achieve market growth.

Register Free at http://pharmexec.com/unfolding

Sponsor:
Wolters Kluwer


Pharma Fights Back: How to Combat Counterfeit Drugs Online
Recorded on: March 24, 2011

Counterfeit pharmaceuticals are a dangerous and growing epidemic. The World Health Organization (WHO) estimates that 10% of all drug sales are counterfeit. And, when it comes to the Internet, counterfeit drugs and suspicious pharmacies find fertile ground. The online proliferation of fake drugs puts corporate reputations and profits at risk, but more importantly, they endanger the lives of consumers. How is your company combating this illicit, complex and global drug supply chain? Realizing the need to stay ahead of these sophisticated fraudsters, Purdue Pharma took proactive action against the online sale of counterfeit drugs. In this informative webinar, industry-veteran Richard Widup, Senior Director of Corporate Security at Purdue Pharma, will share his proven strategies for successfully shutting down online counterfeiters and securing the integrity of the pharmaceutical supply chain.

Register Free at http://pharmexec.com/combat

Sponsor:
MarkMonitor

Game Changed: Unleashing Your Sales and Marketing Potential with iPad?
Recorded on: February 23, 2011

What does the "super gadget" that stormed the consumer world have to offer life sciences sales and marketing organizations? Join us on Wednesday, February 23rd when thought leaders from the industry gather to share their perspectives on emerging trends and market opportunities. Now that iPad has gotten the attention of both life sciences companies and their customers, how can sales and marketing leverage the platform for facilitating more meaningful dialogue between life sciences sales organizations and their stakeholders? Does the iPad with its simple yet elegant multi-touch user interface actually boost user adoption? And how about grasping customers attention? How can marketing arm their sales organization with powerful educational and promotional materials and be assured they are reaching the right prescribers at the right time?

Register Free at http://pharmexec.com/unleash

Sponsor:
Cegedim Relationship Management

Marketing With Power to Nurse Practitioners and Physician Assistants
Recorded on: February 9, 2011

Nurse Practitioners and Physician Assistants. Who are they? Where are they? What makes them tick? What do they want from you? What are the changes you will see in the professions in the coming years? These are just some of the things you will learn during this compelling and important webinar presented by 30 year pharma industry executive, Spencer Falk, MBA and 35 year Physician Assistant and industry executive David Mittman.

Register Free at http://pharmexec.com/power

Sponsor:
Clinician 1 & PANPharma